Ostertag Eric
Insider CIK 1765987 · PSTX Executive Chairman, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2023-02-01 | 2023-02-03 | 11,776 | $7.00 | $82.4K | 827,320 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | P Buy | 2022-08-08 | 2022-08-10 | 142,857 | $3.50 | $500.0K | 838,824 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2022-08-03 | 2022-08-05 | 160,696 | $3.69 | $593.0K | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-01 | 10,792 | — | $0 | 10,792 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-01 | 118,708 | — | $0 | 118,708 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-01 | 89,500 | — | $0 | 692,967 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | G Gift | 2021-12-30 | 2022-02-01 | 48,902 | — | $0 | 580,292 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | G Gift | 2021-12-30 | 2022-02-01 | 93,955 | — | $0 | 603,467 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-11-19 | 2021-11-22 | 1,000 | — | $0 | 739,995 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-11-19 | 2021-11-22 | 1,000 | $9.15 | $9.2K | 697,422 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-11-08 | 2021-11-10 | 9,873 | $7.09 | $70.0K | 3,659,503 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-11-08 | 2021-11-10 | 9,051 | $7.09 | $64.2K | 3,358,455 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-10-11 | 2021-10-13 | 18,525 | — | $0 | 740,995 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-10-11 | 2021-10-13 | 18,525 | $9.15 | $169.5K | 696,422 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 10,450 | $7.02 | $73.4K | 3,669,376 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 9,579 | $7.02 | $67.2K | 3,367,506 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-22 | 20,000 | $8.00 | $160.0K | 160,696 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-15 | 20,000 | $8.14 | $162.8K | 180,696 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-09-13 | 2021-09-15 | 2,757 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-09-13 | 2021-09-15 | 18,524 | — | $0 | 759,520 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-09-13 | 2021-09-15 | 18,524 | $9.15 | $169.5K | 675,415 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-09-13 | 2021-09-15 | 2,757 | $1.17 | $3.2K | 656,891 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 31,963 | $8.34 | $266.6K | 3,679,826 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 29,299 | $8.34 | $244.4K | 3,377,085 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 24,463 | $8.46 | $207.0K | 3,406,384 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 26,686 | $8.46 | $225.8K | 3,711,789 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-08-06 | 2021-08-10 | 111,149 | — | $0 | 778,044 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-08-06 | 2021-08-10 | 111,149 | $9.15 | $1.02M | 654,134 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-04 | 10,401 | $7.99 | $83.1K | 3,738,475 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-08-03 | 2021-08-04 | 9,535 | $7.99 | $76.2K | 3,430,847 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-04 | 7,167 | $8.13 | $58.3K | 3,748,876 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-08-02 | 2021-08-04 | 6,570 | $8.13 | $53.4K | 3,440,382 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-02 | 2021-07-06 | 13,076 | $8.90 | $116.4K | 3,446,952 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-02 | 2021-07-06 | 104 | $9.65 | $1.0K | 3,770,309 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-02 | 2021-07-06 | 14,266 | $8.90 | $127.0K | 3,756,043 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-02 | 2021-07-06 | 96 | $9.65 | $926 | 3,460,028 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-01 | 2021-07-06 | 10,729 | $9.77 | $104.8K | 3,770,413 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-07-01 | 2021-07-06 | 9,834 | $9.77 | $96.1K | 3,460,124 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-03 | 19,476 | $8.34 | $162.4K | 3,469,958 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-03 | 21,246 | $8.34 | $177.2K | 3,781,142 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-03 | 19,701 | $8.61 | $169.6K | 3,489,434 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-03 | 21,493 | $8.61 | $185.1K | 3,802,388 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-05 | 18,775 | $8.44 | $158.5K | 3,823,881 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-05 | 17,211 | $8.44 | $145.3K | 3,509,135 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-05 | 8,765 | $9.01 | $79.0K | 3,526,346 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-05 | 9,561 | $9.01 | $86.1K | 3,842,656 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-05 | 1,617 | $10.32 | $16.7K | 3,852,217 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-05 | 1,483 | $10.32 | $15.3K | 3,532,624 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-05 | 26,170 | $9.63 | $252.0K | 3,534,107 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-05 | 28,549 | $9.63 | $274.9K | 3,853,834 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 29,834 | $9.55 | $284.9K | 3,882,383 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 27,347 | $9.55 | $261.2K | 3,560,277 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 27,290 | $11.54 | $314.9K | 3,590,111 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 29,770 | $11.54 | $343.5K | 3,912,217 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 484 | $12.12 | $5.9K | 3,617,401 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 27,226 | $11.66 | $317.5K | 3,617,885 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 528 | $12.12 | $6.4K | 3,941,987 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 29,702 | $11.66 | $346.3K | 3,942,515 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-02-23 | 2021-02-25 | 111,395 | — | $0 | 2,757 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-02-23 | 2021-02-25 | 111,395 | $1.17 | $130.3K | 542,985 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-02-16 | 2021-02-17 | 133,149 | $10.00 | $1.33M | 200,696 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-02-10 | 2021-02-12 | 67,534 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-02-10 | 2021-02-12 | 12,389 | $10.00 | $123.9K | 333,845 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-02-10 | 2021-02-12 | 67,534 | $1.29 | $87.1K | 431,590 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 889,193 | — | $0 | 889,193 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-25 | 4,462 | $10.00 | $44.6K | 346,234 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 319,039 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-15 | 437,318 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 255,845 | — | $0 | 629,194 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | C Conversion | 2020-07-14 | 2020-07-15 | 350,696 | — | $0 | 350,696 | SEC↗ |